Zimmer Biomet (NYSE:ZBH) said today it launched the Comprehensive Augmented baseplate component designed for its Comprehensive reverse shoulder system, having won FDA approval in January this year.
The Warsaw, Ind.-based company said that the device had been used in its first shoulder procedure, performed by Dr. John Sperling of the Mayo Clinic.
Zimmer Biomet said that the Comprehensive Reverse shoulder system, and its newly released Comprehensive Augmented baseplate component, are an alternative system to bone grafting and eccentric reaming for patients with glenoid defects who are undergoing shoulder reconstruction.
“The new Augmented baseplate rounds out Zimmer Biomet’s Comprehensive Shoulder portfolio and provides solutions that help surgeons with difficult glenoid deformity cases,” Zimmer global extremities biz GM Orsa Britton said in a press release.
Late last month, Zimmer Biomet released seven-year follow-up results from a study of its Mobi-C cervical disc device designed for total disc replacement procedures, touting lower pain, maintained motion range and other benefits.